What is AngioDynamics's impairment charges?

AngioDynamics (ANGO) reported impairment charges of $38K in Q4 2025.

How has AngioDynamics's impairment charges changed year-over-year?

AngioDynamics's impairment charges decreased by 0.0% year-over-year, from $38K to $38K.

What is the long-term trend for AngioDynamics's impairment charges?

Over 3 years (2021 to 2025), AngioDynamics's impairment charges has grown at a -100.0% compound annual growth rate (CAGR), from -$10K to $0.

What does impairment charges mean?

Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.

AngioDynamics ANGO Impairment Charges

Impairment Charges at other companies

Merit Medical SystemsMMSI

$137K+328%

MedtronicMDT

$0—

HaemoneticsHAE

$77.25M—

NordsonNDSN

$3.14M—

Other financials

Income statement

See full

Revenue$78.4M+8.9%

Gross profit$41.5M+6.7%

Operating income-$13.0M-29.8%

Net income-$8.1M-83.4%

EPS (diluted)-$0.19-72.7%

Balance sheet

See full

Cash & equivalents$37.8M-15.5%

Total debt$7.9M+10.2%

Total equity$173.4M-6.7%

Total assets$260.7M-8.7%

Cash flow

See full

Operating cash flow-$3.1M+76.4%

CapEx$1.0M-43.5%

Free cash flow-$4.1M+72.4%

Valuation

See full

Market cap$564.42M+38.7%

Enterprise value$534.51M+48.0%

P/S1.8×+0.4×

Profitability

See full

Gross margin54.3%-0.1pp

Operating margin-11.3%-2.9pp

Net margin-10%-2.4pp

FCF margin5.5%—

Returns & leverage

See full

Return on equity-17.5%-2.2pp

Debt / equity0×0.0×

Current ratio2.4×+0.1×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf.

The official record: AngioDynamics’s 10-Q, filed April 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's impairment charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AngioDynamics's impairment charges?: AngioDynamics (ANGO) reported impairment charges of $38K in Q4 2025.
How has AngioDynamics's impairment charges changed year-over-year?: AngioDynamics's impairment charges decreased by 0.0% year-over-year, from $38K to $38K.
What is the long-term trend for AngioDynamics's impairment charges?: Over 3 years (2021 to 2025), AngioDynamics's impairment charges has grown at a -100.0% compound annual growth rate (CAGR), from -$10K to $0.
What does impairment charges mean?: Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.